Fresh analysis indicates that individuals who come off popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who end traditional lifestyle programs.
Findings released in a prominent health publication points out that while obese people often shed substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Users buying such drugs should be informed of the risk of rapid rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.
Such speed of regain implies a return to original weight in about one and a half years.
Comparing Treatments
The analysis, which looked at dozens of trials involving thousands of patients, compared the effects of the injectable medications with older methods.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone usually have a less rapid weight regain—approximately 0.1 kg a month—post-intervention.
The Reason for the Quick Regain
Nutrition scientists propose the mode of action of the jabs is key to understanding the accelerated weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Sustained high doses of GLP-1 concentrations far above than normal might result in the system to produce less of its own natural hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication means appetite is no longer kept in check, making binge eating much more probable."
A Chronic Disease?
Medical guidelines advise the injections for people with weight-linked medical conditions, alongside prescribed lifestyle changes.
Professionals argue that, given the likelihood of relapse, the treatment might need to be ongoing.
This opinion is reinforced by drug manufacturers, who say that the findings "emphasize the long-term nature of obesity," similar to managing conditions like hypertension.
Patient Testimonies
Users who have stopped the jabs report a intense return of cravings.
"It was like a switch that goes on and I was suddenly extremely hungry," recalled one woman.
The struggle is exacerbated if individuals have not established lasting dietary or behavioural changes during treatment.
Significant Interest
Figures show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Finally, clinicians stress that while these medications are effective tools for shedding pounds, they are not a standalone solution and lasting health benefits relies on combined lifestyle support.
